“With the exception of safe water, no other modality, not even antibiotics, has had such a major effect on mortality reduction …” Plotkin S, OrensteinW, Offit P; Vaccines, 5th Ed. Saunders, 2008.
Biovac has supplied vaccines for the Expanded Programme on Immunisation (EPI) in South Africa since 2003. For the last 15 years we have played a pivotal role in supporting the South African Department of Health during introductions of new vaccines and during vaccination campaigns.
Currently, we supply over 15 million doses of vaccines annually to the South African provinces.
The following are the vaccines supplied in South Africa and the diseases they prevent:
| Disease | Vaccine |
|---|---|
| Tuberculosis | Bacille Calmette-Guerin Vaccine – BCG |
| Measles | Measles Vaccine |
| Pneumonia | Pneumococcal Conjugate Vaccine |
| Hepatitis B | Hepatitis B Vaccine |
| Diphtheria, Tetanus, Pertussis, Poliomyelitis, Haemophilus influenzae b infection and Hepatitis B | Hexavalent Vaccine |
| Tetanus | Tetanus Toxoid Vaccine |
Beyond South Africa, The Biovac Institute supplies vaccines and other biologicals within the South African Development Community (SADC) region and continues to explore relationships to expand our reach.